CRIS Current Research Information System

ZAMAGNI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.683
NA - Nord America 1.617
EU - Europa 1.209
AF - Africa 145
SA - Sud America 73
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.600
CN - Cina 538
SG - Singapore 521
IT - Italia 397
VN - Vietnam 254
GB - Regno Unito 156
SE - Svezia 155
DE - Germania 118
HK - Hong Kong 105
KR - Corea 100
NL - Olanda 83
IN - India 81
CI - Costa d'Avorio 63
RU - Federazione Russa 56
BR - Brasile 48
IE - Irlanda 43
FI - Finlandia 37
FR - Francia 32
BG - Bulgaria 28
TG - Togo 26
SC - Seychelles 24
JO - Giordania 21
UA - Ucraina 21
AT - Austria 18
CH - Svizzera 18
JP - Giappone 17
AR - Argentina 15
ID - Indonesia 15
CA - Canada 12
ZA - Sudafrica 12
BE - Belgio 11
PL - Polonia 11
EE - Estonia 9
BD - Bangladesh 7
EG - Egitto 7
EC - Ecuador 6
ES - Italia 5
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 3
IR - Iran 3
MX - Messico 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
DZ - Algeria 2
TH - Thailandia 2
TR - Turchia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CO - Colombia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
VE - Venezuela 1
Totale 4.733
Salva come PNG Salva come JPEG
Città #
Singapore 360
Ashburn 258
Hefei 205
Fairfield 142
Chandler 133
Southend 130
Hong Kong 105
Bologna 103
Seoul 99
Santa Clara 71
Houston 66
Wilmington 65
Abidjan 63
Seattle 60
Woodbridge 60
Beijing 59
Dallas 51
New York 49
Ho Chi Minh City 48
Ann Arbor 47
Cambridge 46
Boardman 43
Dublin 43
Princeton 42
Hanoi 40
Helsinki 32
Sofia 28
Lomé 26
Los Angeles 26
Dong Ket 23
Hyderabad 22
Amman 21
Milan 20
Bengaluru 19
Nanjing 18
Florence 17
Tokyo 17
Berlin 16
Bern 16
Turin 15
Vienna 15
Westminster 15
Frankfurt am Main 13
Jakarta 13
Redondo Beach 13
Saint Petersburg 13
Amsterdam 12
Padova 12
Buffalo 11
Chicago 11
Haiphong 10
Jacksonville 10
Shanghai 10
Casalecchio di Reno 9
Cesena 9
Falkenstein 9
Falls Church 9
Munich 9
Redmond 9
Tongling 9
Brussels 8
Guangzhou 8
Jinan 8
Warsaw 8
Lugo 7
Nuremberg 7
São Paulo 7
Boydton 6
Bắc Ninh 6
Forlì 6
Hebei 6
Nanchang 6
San Diego 6
Shenyang 6
Abeokuta 5
Changsha 5
Des Moines 5
Ningbo 5
Ninh Bình 5
Pedrengo 5
Phoenix 5
Quận Một 5
Redwood City 5
Rome 5
Stockholm 5
Tianjin 5
Bremen 4
Castel Maggiore 4
Chengdu 4
Council Bluffs 4
Da Nang 4
Dearborn 4
Hải Dương 4
Mülheim 4
Quito 4
Ravenna 4
Yubileyny 4
Andover 3
Atlanta 3
Brasília 3
Totale 3.133
Salva come PNG Salva come JPEG
Nome #
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 267
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 227
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 217
Management of malignant cutaneous wounds in oncologic patients 214
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. 208
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 199
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 194
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 184
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 178
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 169
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 155
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. 154
null 150
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 147
Relevance of ARID1A Mutations in Endometrial Carcinomas 145
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment 141
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 140
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 140
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control 136
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) 135
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 135
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival 128
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 127
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 124
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. 123
Characterization of BRCA Deficiency in Ovarian Cancer 103
Exploring pain management in breast cancer: key findings from the ARISE study 95
Radiotherapy in uterine sarcoma: a narrative review of international guidelines 95
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 93
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis 76
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 70
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma 62
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. 59
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System 58
Totale 4.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.331
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 0 0 0 0 0 7 4 19 38 10 14 109
2021/2022494 42 23 31 54 43 18 11 30 22 60 99 61
2022/2023579 54 93 30 52 37 41 17 27 112 15 44 57
2023/2024299 31 28 15 14 16 77 11 46 11 12 16 22
2024/20251.135 104 86 112 63 102 56 98 74 28 104 108 200
2025/20261.407 254 396 226 235 252 44 0 0 0 0 0 0
Totale 4.848